Btg Share Discussion Threads

[fhmktg] 08/11/2016 16:35

Give over!At 2pm Shire,AZN and GSK ALL took a dive!

[harijan] 08/11/2016 15:54

It's the Clinton factor, stupid! Haven't you been keeping up with her promises to sort out the overcharging pharma companies? Promises which, of course, she cannot fulfil. And there's some doubt about whether she really will want to.

[cockneytrader] 08/11/2016 14:16

Varithena - the elephant in the room!

[bargainbob] 08/11/2016 12:58

I think the FDA should be paying BTG for not knowing what they were doing .

[fhmktg] 08/11/2016 12:31

Who will be liable for the cash- BTG or the previous directors of Biocompatibles?Under due diligence presumably there would have been some liability for previous misdemeanours which subsequently come to light?Glad it's settled though!

[gregmorg] 08/11/2016 11:00

Yup you are correct Megan. BTG announced this settlement on 6 October. It relates to a period prior to acquisition. The way it is presented here does not look good at all--but I guess it was not intended to either!

[bargainbob] 07/11/2016 17:20

Bb raises his target to 8 by Christmas . please pretty please Santa.

[a1ord53] 03/11/2016 13:51

BTG Plc : Stifel raises target price to 725p from 640p
* BTG Plc : Stifel raises to buy from hold

[bargainbob] 03/11/2016 13:25

Oh know you in this too Monty

[montyhedge] 03/11/2016 09:07

News letter pumping this for the figures on the 15th November.

[spyder] 02/11/2016 06:17

In theory, £6.15 should be the bottom of this current period of the trading range. If the shares bounce from here, that would be a very positive sign.
Similarly, I would see a drop below £6.00 as extremely bearish - as well as being rather silly!!
FWIW.

[bargainbob] 01/11/2016 22:05

Could be another takeover going down in the background.

[elsa7878] 01/11/2016 20:58

From recollection they are expecting overall revenues of $1.5 to $2 billion within 4 years. This year is going to be around half of that.

[gregmorg] 01/11/2016 19:27

Not sure the deep concerns expressed re Varithena revenues are firmly based. The product is unquestionably taking longer to build up as we all know and the company has already acknowledged, but it is happening!

The company had indicated quite recently that an increasing number of US medical insurers have started accepting Varithen treatment so further penetration was underway.

Admittedly these insurers have been using the interim Code CPT 37999 in various States as Varithena had not yet received a dedicated specific code. So in recent time more insurers have written Varithena into their policies and are accepting that code and are paying physicians at an appropriate rate.

No doubt we will get an update on all activities quite shortly.

[bargainbob] 01/11/2016 17:33

Shire results after they over stretched themselves, costing btg dear . If anything makes BTG seem a once in a life time buy.

[bargainbob] 01/11/2016 17:33

Shire results after they over stretched themselves, costing btg dear . If anything makes BTG seem a once in a life time buy.

[cockneytrader] 01/11/2016 16:43

Why stupid. Varithena has bombed. What will replace lemtrada and zytiga revenues?

[a1ord53] 01/11/2016 16:27

Its stupid , Deutsche Banks target 865p , Numis 900p and even RBC downgraded to 790p and not to 620p
Whats going on ?
Results on 15 th of November will be better than preliminory
What mm and traders expect ?

[steeplejack] 01/11/2016 09:58

All to get a bit of business going as Hilary closes in on the White House......or does she?

[waterloo01] 01/11/2016 09:30

01 Nov 16 RBC Capital Markets Sector Performer 630.75 910.00 790.00 Downgrades

[waterloo01] 01/11/2016 09:30

I think there was a broker downgrade. Shire don't doing so well, key patent cliffs and disappointment re Varisolve.